Tomomi Kogiso
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 03, 2026
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.
Journal: Journal of gastroenterology
Published: February 21, 2026
Clinical Outcomes of Fontan-Associated Hepatocellular Carcinoma: a Single-Center Retrospective Study.
Journal: Journal of gastroenterology and hepatology
Published: December 17, 2025
Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 22, 2025
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease.
Journal: Journal of gastroenterology
Published: August 30, 2024
Evaluation of diagnostic criteria for mild-to-advanced stages of Fontan-associated liver disease: A nationwide epidemiological survey in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 27, 2024
Prediction of hepatocellular carcinoma in patients with Fontan-associated liver disease using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 27, 2024
Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease.
Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 10, 2024
Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 04, 2023
A case of acute liver failure caused by Budd-Chiari syndrome salvaged by brain-dead donor liver transplantation.
Journal: Clinical journal of gastroenterology
Published: July 27, 2023
Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease.
Journal: PloS one
Published: July 26, 2023
Algorithm of ascites management for liver cirrhosis in the tolvaptan era: Paradigm shift treatment improves the outcomes of cirrhotic patients?
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 07, 2023
Last Updated: 09/26/2026